K2E (p.Lys2Glu) variant of CASQ2 (Calsequestrin-2)

K2E (p.Lys2Glu) in CASQ2 (Calsequestrin-2) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as uncertain significance in the context of Cardiovascular phenotype. The available variant effect predictions contribute to a CATVariant prioritization score of 0.25 / 1. The record also includes population frequency data and structural context.

K2E (p.Lys2Glu) variant details